Share to Facebook Share to Twitter Share to Linkedin In trading on Tuesday, shares of Novartis crossed below their 200 day moving average of $85.10, changing hands as low as $84.78 per share. Novartis...
Tag: Novartis
Novartis CEO says Covid to become endemic, calls for better pandemic preparedness
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images The chief executive of Swis...
Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...
U.S. Companies In China Worried Covid Surge Will Damage Prospects After Upbeat G20 Meeting
American Chamber of Commerce in Shanghai Chairman Sean Stein Sean Stein U.S. companies in China are worried that a surge in Covid cases in the country will hurt consumer and investment spending right ...
3 Productivity Tips For Focusing This Fall
As Summer Fridays and out-of-office messages wind down, it’s essential that we find new ways to stay … [+] focused. Shutterstock America’s employees have reported increased distraction in 2022 w...
Close The Gap Between Discovery Research And Patient Care: Cancer Moonshot Pathways
“New, transformative technologies will improve and simplify screening and we should prioritize these … [+] advancement efforts” Andrea Myers Note: President Joe Biden in February lau...
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
U.S. Firms In Shanghai Cutting Revenue Forecasts, Investment Plans After Lockdowns — Survey
A police patrol vehicle monitors the crowd along Shanghai’s iconic Bund on June 1. Lockdown … [+] restrictions have eased in much of the city this month but residents face stringent travel...
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...